Family · Pharmaceutical analytical standards
Luliconazole
A topical imidazole antifungal, first marketed in Japan in 2005 and approved in the United States in 2013: it is used against skin infections caused by dermatophytes, such as athlete's foot, tinea cruris and tinea corporis. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It contains only one of the two mirror-image forms of its molecule, the (R) form, while many other azole antifungals are used as a mixture of both.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
